Please Wait...

Proven Expertise in Post-Approval Research

Your drug has been approved for the marketplace, but your work isn't finished. Post-approval studies need to be carried out to obtain real-world data, assess your product's safety profile, and support your product's lifecycle. Such studies require an innovative mindset, a specialized infrastructure, unique processes, customized technology, and targeted expertise. Bioclinica's Post-Approval Research division delivers all that and more.

Customized Post-Approval Research Strategies

Bioclinica's Post-Approval Research division is comprised of a dedicated team with experience in designing and executing post-approval research for observational studies, post-marketing commitments, post-approval safety studies, and large, simple trials. Our full-service solution includes comprehensive post-approval services, from program design and protocol development to regulatory submissions.

Our experienced Post-Approval Research team develops and implements customized strategies for each drug, specifically structured for the needs of post-approval research. Our tactical approaches are streamlined and patient-centric, drawing on real-time data collection and analysis.

The Bioclinica Difference

With a dedicated Post-Approval Research division, you benefit from:

  • SOPs specifically developed for post-approval research
  • Enhanced patient engagement, compliance, and retention
  • An increase in data collection by 25-30% by proven methodologies
  • Insightful study design that anticipates physician and patient needs
  • Superior data access and analysis for deep insights
  • Greater efficiency, resulting in cost savings of 15-20%
  • Solutions that maximize your return on investment
  • An expert staff 100% focused on post-approval research
  • Consultations and customized study design to optimize outcomes
  • Proven post-approval methodology and validated processes
  • Fully-integrated and flexible technologies created for post-approval studies

ADDITIONAL RESOURCES

Conducting post-approval research requires a unique mindset and specialized infrastructure. Do you have what it takes?

On Demand WEBINAR

Patient Centric Post-Approval Research: It's Time to Rethink How Post-Approval Studies Are Done

On Demand WEBINAR

Maximize the ROI of Your Post-Approval Research

Download White Paper

Post-Approval Research

Download Brochure

Patient Outreach Center

Download Info Sheet

Program Coordinating Center

Download Info Sheet

Post-Marketing Research

Download Info Sheet

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Our #Alzheimers expert's work will B showcased at #ADPD2017 Preview here https://t.co/nnbO9q8lVk @adpdnet
bioclinica (18 hours ago)
#FunFriday ! A long time ago in a lab far far away.... https://t.co/2MrgKJhS07
bioclinica (20 hours ago)
Smiles all around on Pizza Day today for @bioclinica eHealth in Audubon compliments of our CTO Andrew Masters. This… https://t.co/PbFoWnxn3B
bioclinica (Yesterday)
Missed Tuesday's webinar on agile #IRT? No worries! Catch it here > https://t.co/kKUIQEB0vI #Pharma #CRO #eClinical
bioclinica (Yesterday)
RT @ACROhealth: Where do you stand on regulating #mHealth & #Wearables in #clinicalresearch? w/ @bioclinica, @ICONplc, @INC_Research https:…
bioclinica (3 days ago)
RT @ACROhealth: ICYMI: @CCTAwareness’ Infographic on #clinicaltrials awareness for #Alzheimer’s and Parkinson’s treatments. https://t.co/84…
bioclinica (3 days ago)

Latest Blogs: